Kidney Cancer

Long-term follow-up of patients treated with radio frequency ablation performed

Published in Cancer Weekly, August 2nd, 2005

Scientists conducted a long-term follow-up of patients with renal cell carcinoma (RCC) who were treated with radio frequency ablation.

According to recent research from the United States, "We defined the role of radio frequency ablation in the treatment of RCC."

"A total of 16 patients with biopsy proven RCC were treated with radio frequency ablation in an outpatient setting and followed for a minimum of 4 years. Of the 16 patients, 5 died before 4 years of follow-up of unrelated causes. All except 1 tumor was successfully treated," explained W.S. McDougal and colleagues, Harvard Medical School.

The researchers concluded, "All...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-08-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry